Nektar pads wallet with $90M manufacturing plant sale to Ampersand
Fierce Pharma
NOVEMBER 4, 2024
The deal is expected to extend Nektar's cash runway into 2026 and help the company hone its development of novel immunology drugs.
This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Fierce Pharma
NOVEMBER 4, 2024
The deal is expected to extend Nektar's cash runway into 2026 and help the company hone its development of novel immunology drugs.
Fierce Pharma
FEBRUARY 14, 2024
FDA unleashes multiple warning letters targeting insanitary manufacturing and online sales of unapproved Mounjaro, Ozempic fkansteiner Wed, 02/14/2024 - 05:10
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
JANUARY 4, 2024
As bankers predict a rise in private equity exits this year, one of 2024’s M&A moves could come from the drug manufacturing realm. billion), Bloomberg reported Wednesday, citing people close to the talks.
Evolve Your Success
FEBRUARY 26, 2025
From Ted Talks to the medical sales podcast! In this episode, he discusses the essential sales skills required for success as a medical sales representative. Discover Andy’s expertise as he guides high-performing individuals, executive sales leaders, and professional athletes through his coaching and training organization.
Fierce Pharma
DECEMBER 4, 2023
A challenging year for the biotech industry has taken a heavy toll on Chinese manufacturer WuXi Biologics, sending the company’s stock plummeting nearly 24% Monday. WuXi Biologics expects to miss its original sales target for the year by around $400 million, thanks to reductions across its development and manufacturing services.
Fierce Pharma
NOVEMBER 2, 2023
But strong demand continues to push sales of the GLP-1/GIP agonist to new highs ahead of an FDA decision on weight loss. | As strong demand continues to push Mounjaro sales to new highs, Eli Lilly CEO David Ricks said the company is "not done with" manufacturing expansions.
Fierce Pharma
MARCH 30, 2023
Fierce Pharma Asia—Takeda's manufacturing expansion; Leqembi's sales prospects; GSK's PrEP generics aliu Thu, 03/30/2023 - 16:18
Fierce Pharma
AUGUST 1, 2024
sales of $304 million during the second quarter, Regeneron’s high-dose version of Eylea came up just short of analyst projections. | sales had declined in each of the previous three quarters. The launch of Regeneron's Eylea HD has helped the Eylea franchise to a rebound after U.S. The target date is August 22.
Fierce Pharma
OCTOBER 3, 2024
legislative branch, two companies named in the bill are reportedly weighing sales of certain units and facilities. WuXi AppTec has put its cell and gene therapy manufacturing arm, WuXi Advanced Therapies, on the market, The Financial Times reported Thursday. As the BIOSECURE Act works its way through the U.S.
Fierce Pharma
SEPTEMBER 3, 2024
Reddy’s has been cut off from China’s bulk-buy drug procurement program after an inspection turned up “serious defects” in the company’s manufacturing operations. In addition, Dr.
pharmaphorum
NOVEMBER 12, 2024
AstraZeneca plans to invest a whopping $3.5 AstraZeneca plans to invest a whopping $3.5
MedCity News
FEBRUARY 8, 2024
Meanwhile, BioNTech will gain access to Autolus’s cell therapy manufacturing assets as well as technologies that could support the R&D of in vivo therapies and antibody drug conjugates. Autolus will apply the capital to its CAR T-cell therapy currently under FDA review in cancer and in early clinical development in lupus.
Fierce Pharma
FEBRUARY 9, 2024
As Catalent gets ready to join the Novo fold, the contract manufacturing juggernaut continues to slide on its diminishing COVID-19 business. billion.
MedCity News
NOVEMBER 2, 2022
Rubius Therapeutics was unable to secure financing to carry out its pivot to a new manufacturing process for its red blood cell-based cell therapies. The once high-flying biotech is now exploring options that could include a sale of the business or a merger with another company.
Fierce Pharma
AUGUST 3, 2023
The division took a major hit from production timing and COVID-related sales downturns. The division took a major hit from production timing and COVID-related sales downturns.
Fierce Pharma
JULY 25, 2024
While manufacturing and supply hitches have troubled the rollout of Sanofi’s key respiratory syncytial virus (RSV) drug, the near-term expected approval of a pair of new filling lines is giving the | While manufacturing and supply hitches have troubled the rollout of Sanofi’s key respiratory syncytial virus drug, the near-term expected approval of (..)
Integrity Solutions
MARCH 4, 2020
As they weigh purchase options and evaluate vendors, B2B buyers expect sales teams and their companies to behave in ethical ways. . Transparency Is Key to Creating an Ethical Sales Culture . The manufacturer had had some slip-ups, and that had created a big upheaval internally. . Ethical sales practices build trust.
Evolve Your Success
OCTOBER 24, 2023
OEM Sales is about creating solutions to win customers and making an impact, one deal at a time. In this episode, we have Sean Pitts from GCX corporation to uncover the ins and outs of OEM Sales. Sean discusses the critical qualities that make an exceptional OEM sales representative. If y ou ask, “W hat is OEM sales ?”
Fierce Pharma
NOVEMBER 2, 2023
Ever since Novo Nordisk won FDA approval for its GLP-1 weight-loss med Wegovy more than 2 years ago, analysts and investors have been keeping a close eye on the blockbuster drug launch.
Axxelus
DECEMBER 21, 2021
So, just how big is the medical sales industry? The manufacture and sale of medical implants, surgical tools, and other equipment is an enormous industry.
World of DTC Marketing
MARCH 31, 2022
With the money it costs us, the Government could encourage a private company to build a manufacturing facility for insulin while offering tax incentives. Dr. Jing Luo says the list price of insulin — the price set by manufacturers but not necessarily what patients or providers pay — has increased between 300% to 500%. billion to $5.7
Integrity Solutions
APRIL 5, 2021
This begs the question: Does your team have the confidence and skill to take advantage of these complex sales opportunities? Just like a football team must strengthen its performance to be competitive after moving up to a stronger division, sales teams need to sharpen their capabilities to compete and win in the coming economy.
Fierce Pharma
MAY 15, 2024
Two years ago, when Merck KGaA restructured, forming a new life science business, the goal was to maximize the enticing potential of its contract development and manufacturing organization (CDMO). |
Pharmaceutical Technology
JULY 15, 2022
Insulin prices made the headlines again as California governor Gavin Newsom announced plans on 7 July for the state to manufacture low-cost insulin. The state plans to work directly with a contract manufacturing organization (CMO) to manufacture low-cost insulin. In-house manufacturing the norm.
Fierce Pharma
SEPTEMBER 13, 2023
Moderna CEO Stéphane Bancel is optimistic that the company will beat the low end of its $6 billion to $8 billion COVID vaccine sales estimate for 2023. But his optimism comes as Moderna reportedly eyes manufacturing cuts as it shifts to an endemic market response.
Pharmaceutical Representative Training
MARCH 17, 2025
The Evolution of Pharma Sales: Combining AI and Social Media to Promote Brands Pharmaceutical businesses now have access to a whole new level of insights due to social media. 1] The Challenges Pharma Sales Teams Face Teams encounter certain challenges that reduce the efficacy of conventional approaches.
World of DTC Marketing
JULY 8, 2022
In 2020, over 75% of AbbVie’s’ sales were made to American consumers, yet only 1% of AbbVie’s’ income was reported in the United States for tax purposes. prescription drug sales signals that big pharma will do anything to avoid hurting profits. taxation on foreign earnings for U.S. AbbVie Biotechnology Ltd.
Fierce Pharma
MARCH 19, 2024
Still, the Chinese contract manufacturer finds itself embroiled in a national security crackdown in the U.S., In moments of great uncertainty, sometimes the best approach is to just press on. CDMO WuXi AppTec reported solid performance in 2023 and expects good things for the coming year, too.
Contrarian Sales Techniques
NOVEMBER 21, 2024
For pharma sales reps, these programs are not just tools for market penetration – they’re lifelines that improve healthcare accessibility across the country. For example, a major insulin manufacturer might partner with hospitals to offer subsidized insulin for low-income patients. What Are Drug Access Programs?
Evolve Your Success
SEPTEMBER 18, 2024
Unlock the secrets to excelling in medical sales! Delve into Jon’s personal story, from the influence of his author father to his own four-year endeavor of writing a book aimed at guiding future medical sales reps. For those eager to up their sales game, this episode is packed with actionable strategies and time management tips.
Evolve Your Success
MAY 8, 2024
The world of medical sales is undergoing a seismic shift and at the heart of this transformation is Paul Hoffschmidt, the brains behind Alpha Sophia. As a long-time consultant at Oliver Wyman, he worked with manufacturers and retailers to improve processes and unlock efficiencies in the consumer goods industry.
Healthcare Success
FEBRUARY 24, 2025
This week's podcast dives into successful sales leadership and is relevant to most healthcare verticals, including B2B sales in SaaS, pharmaceuticals, medical device, hospitals, etc. It also applies to high-value B2C sales, e.g., elective surgeries, orthodontics, senior care, and residential treatment centers. Why Listen?
World of DTC Marketing
OCTOBER 5, 2021
last year gave away more than $23 billion in rebates to insurance intermediaries, but still netted $50 billion in sales. sales of the 20 top-selling drugs worldwide totaled $101.1 billion while sales to the rest of the world totaled nearly $57 billion. Drugs with significant sales revenue disparities between the U.S.
Integrity Solutions
MAY 24, 2023
What Is Sales Training? Sales Training – at its heart – should be about learning to uncover and identify customer needs, thus creating value and providing service. Successful sales people know is about doing something for the customer – not to the customer.
Fierce Pharma
JUNE 26, 2024
The toll of Sanofi spinoff EuroAPI’s newly unveiled restructuring scheme is coming into focus as the manufacturer moves forward with its sweeping four-year efficiency plan. |
Evolve Your Success
MAY 30, 2023
Master the art of sales in the medical field and unlock your true potential as a representative. Welcome to the Medical Sales podcast. In this episode, he discusses the essential sales skills required for success as a medical sales representative. I lead a sales and leadership training organization.
pharmaphorum
JANUARY 24, 2023
Drastic steps need to be taken if the UK is to reverse a steep decline in medicines manufacturing in recent years, according to a cross-industry coalition. Over the same period, similar countries – including Ireland, France, and Germany – have been moving to boosting manufacturing productivity, output, and exports.
European Pharmaceutical Review
FEBRUARY 2, 2023
While maintaining a healthy manufacturing industry for production of ‘high tech’ pharmaceuticals, Europe has stepped away from manufacturing essential medicines and active pharmaceutical ingredients (APIs) due to unrelenting price pressures and is now heavily reliant on the import of these critical ingredients.
European Pharmaceutical Review
JANUARY 12, 2024
New technologies at the facility will support the increased manufacturing capacity, the company stated on X. A quarter of these net sales were reinvested into research to find new therapies and treatments in disease areas with high unmet needs. The expansion will boost exports of medicines from Greece to the US market.
Evolve Your Success
MARCH 29, 2022
Brett worked in medical sales as an associate when he felt incomplete because it was not his dream role. Clair: Medical Device Associate Sales Rep To Sales Rep With Evolve Your Success. It’s special to me because this guest went through one of our programs that helps professionals get into medical sales.
European Pharmaceutical Review
SEPTEMBER 28, 2023
There has been a steady stream of developments in the vaccine manufacturing space throughout 2023. A notable milestone was Moderna’s announcement in April that it had, following finalisation of a ten-year strategic partnership with the UK Government, commenced construction of its mRNA vaccine manufacturing technology centre.
Medical Device Success
APRIL 5, 2020
Reading time: 3 – 4 minutes Episode 2 of the season – Medtech International Marketing and Sales Efforts During Covid-19. Season One – Covid-19 – how Medtech companies can respond in marketing, sales and operations. Non-US manufacturers are much more sensitive to their international distribution networks. contact link.
European Pharmaceutical Review
FEBRUARY 3, 2023
Switzerland-based contract development and manufacturing organisation (CDMO) CARBOGEN AMCIS has opened a new facility in France, dedicated to the custom development and production of sterile injectable drug products. HPAPI contract manufacturing to value $14.6
Spotio
APRIL 30, 2024
Sales reps in the manufacturing industry face unique challenges. Competition is fierce, buyers often come to the table with preconceived notions—notions that must be adjusted to make sales—and prices continue to plummet in an attempt to win business. A strong manufacturing sales training program can help.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content